The purpose of this study is to assess the overall clinical performance of a contact lens made with a modified manufacturing process.

The expected duration of subject participation in the study is approximately 4 days with 2 scheduled visits.

Key Inclusion Criteria:

• Successful wearer of spherical soft contact lenses of the same brand in both eyes for a minimum of 5 days per week and 10 hours per day during the past 3 months.
• Manifest cylinder equal to or less than 0.75 diopter (D) in each eye.
• Best corrected visual acuity (BCVA) better than or equal to 0.10 logMAR in each eye.
• Other protocol-specified inclusion criteria may apply.

Key Exclusion Criteria:

• Any use of topical ocular medications and artificial tear or rewetting drops that would require instillation during study participation.
• Wearing habitual contact lenses in an extended wear modality (routinely sleeping in lenses for at least 1 night per week) over the last 3 months prior to enrollment.
• Habitual monovision or multifocal contact lens wearers.
• Other protocol-specified exclusion criteria may apply.

Full Analysis Set: All randomized subjects who are exposed to any study lenses evaluated in this study.

Adverse events (AEs) were collected from time of consent to study exit, approximately 4 days.

AEs were obtained through solicited and spontaneous comments from subjects and through observations by the Investigator. "At Risk" population for ocular AEs is reported in units of eyes; all other populations are reported in units of subjects. This analysis population includes all subjects/eyes exposed to any study lenses evaluated in this study. The Other (Not Including Serious) Adverse Event table reports only the AEs that occurred above a 5% threshold in one or more reporting groups.